Interleukin 10 abolishes the growth inhibitory effects of all-trans retinoic acid on human myeloma cells-Reference-Cited by-同舟云学术

Interleukin 10 abolishes the growth inhibitory effects of all-trans retinoic acid on human myeloma cells

Published:2002-03 Issue:4 Volume:116 Page:787-795
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Otsuki Takemi,Yata Kenichiro,Sakaguchi Haruko,Kurebayashi Junichi,Matsuo Yoshinobu,Uno Masako,Fujii Tomohiro,Eda Sakura,Isozaki Yumika,Yawata Yoshihito,Yamada Osamu,Wada Hideho,Sugihara Takashi,Ueki Ayako

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.0007-1048.2002.03336.x/fullpdf

Reference29 articles.

1. Advances in the treatment of multiple myeloma;Barlogie;Advances in Internal Medicine,1988

2. Growth inhibition of a human myeloma cell line by all-trans retinoic acid is not mediated through downregulation of interleukin-6 receptors but through upregulation of p21 (WAF1);Chen;Blood,1999

3. Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop;Gu;Blood,1996

4. Prognostic factors in multiple myeloma: practicability for clinical practice and future perspectives;Haferlach;Leukemia,1997

5. Evidence for the involvement of both retinoic acid receptor- and retinoic X receptor-dependent signaling pathways in the induction of tissue transglutaminase and apoptosis in the human myeloma cell line RPMI 8226;Joseph;Blood,1998

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone marrow microenvironment- induced regulation of Bcl-2 family members in multiple myeloma (MM): Therapeutic implications;Cytokine;2023-01

2. The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma;Tzu Chi Medical Journal;2021

3. Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma;Mediators of Inflammation;2017

4. High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma;British Journal of Cancer;2016-02

5. Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH;Blood;2012-01-19